Document ID: chunk:federal_register_of_legislation:F2020L00213:reg:9:p3
Version: federal_register_of_legislation:F2020L00213
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9644–10765

multiple sclerosis, which is life-threatening or which results in serious physical or cognitive disability, within the six months before the clinical worsening of multiple sclerosis;
(22)      for women only, using hormonal assisted reproductive therapy within the three months before the clinical worsening of multiple sclerosis;
            Note: hormonal assisted reproductive therapy is defined in the Schedule 1 - Dictionary.
(23)      undergoing a course of therapeutic radiation for cancer, where the affected site was in the field of radiation, before the clinical worsening of multiple sclerosis;
(24)      having received a cumulative equivalent dose of at least 10 sieverts of ionising radiation to the affected site before the clinical worsening of multiple sclerosis;
            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(25)      having dyslipidaemia at the time of the clinical worsening of multiple sclerosis;
            Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.
(26)      inability to obtain appropriate clinical management for multiple sclerosis.